Cerebral Embolic Protection Device During TAVR

Clinical trial NCT07627984 · COMPLETED

Trial details

NCT number: NCT07627984
Sponsor: Shanghai Shenqi Medical Technology Co., Ltd
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Cerebral Embolicprotection Device TAVR

Start date: 2023-09-20
Primary completion: 2025-04-16
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.